CSIMarket
 


The Pennant Group Inc   (PNTG)
Other Ticker:  
 
 

PNTG's Income from Cont. Operations Growth by Quarter and Year

The Pennant Group Inc 's Income from Cont. Operations results by quarter and year




PNTG Income from Cont. Operations (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 4.53 3.69 -2.36 3.83
III Quarter September 4.46 4.99 1.12 4.41
II Quarter June 2.92 -2.60 2.47 4.34
I Quarter March 2.00 1.16 0.91 2.98
FY   13.91 7.24 2.14 15.56



PNTG Income from Cont. Operations fourth quarter 2023 Y/Y Growth Comment
The Pennant Group Inc reported Income from Cont. Operations improvement of 22.74% year on year in the fourth quarter 2023, to $ 4.53 millions, this is lower than The Pennant Group Inc 's recent average Income from Cont. Operations surge of 122.08%.

According to the results reported in the fourth quarter 2023, The Pennant Group Inc achieved the best Income from Cont. Operations growth in Medical Equipment & Supplies industry. While The Pennant Group Inc ' s Income from Cont. Operations rise of 22.74% ranks overall at the positon no. 28 in the fourth quarter 2023.




PNTG Income from Cont. Operations ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December 22.74 % - - -
III Quarter September -10.62 % 345.54 % -74.6 % 145 %
II Quarter June - - -43.09 % -
I Quarter March 72.41 % 27.47 % -69.46 % -
FY   92.11 % 238.32 % -86.25 % -

Financial Statements
The Pennant Group Inc 's fourth quarter 2023 Income from Cont. Operations $ 4.53 millions PNTG's Income Statement
The Pennant Group Inc 's fourth quarter 2022 Income from Cont. Operations $ 3.69 millions Quarterly PNTG's Income Statement
New: More PNTG's historic Income from Cont. Operations Growth >>


PNTG Income from Cont. Operations (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December 1.55 % -26.05 % - -13.15 %
III Quarter September 52.74 % - -54.66 % 1.61 %
II Quarter June 46 % - 171.43 % 45.64 %
I Quarter March -45.8 % - -76.24 % -
FY (Year on Year)   92.11 % 238.32 % -86.25 % -




Income from Cont. Operations fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #1
Healthcare Sector #3
Overall #28

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
988.09 % 122.08 % -123 %
(Sep 30 2023)   (Jun 30 2022)
Income from Cont. Operations fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #1
Healthcare Sector #3
Overall #28
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
988.09 % 122.08 % -123 %
(Sep 30 2023)   (Jun 30 2022)

Income from Cont. Operations by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

The Pennant Group Inc 's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
170.43 % 9.29 % -76.16 %
(Jun 30 2021)  


PNTG's IV. Quarter Q/Q Income from Cont. Operations Comment
The Pennant Group Inc achieved in the IV. Quarter 2023 below company average Income from Cont. Operations growth of 1.55% quarter on quarter, to $ 4.53 millions.

Although the IV. Quarter 2023 PNTG's Income from Cont. Operations sequential growth was below the regular , this was yet promising story, as the current improvement, eclipses the -26.05% Income from Cont. Operations rise in the IV. Quarter 2022

Within Medical Equipment & Supplies industry 24 other companies have achieved higher Income from Cont. Operations quarter on quarter growth. While The Pennant Group Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is 563.


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #25
Healthcare Sector #47
Overall #563
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #25
Healthcare Sector #47
Overall #563
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
170.43 % 9.29 % -76.16 %
(Jun 30 2021)  


PNTG's IV. Quarter Q/Q Income from Cont. Operations Comment
The Pennant Group Inc achieved in the IV. Quarter 2023 below company average Income from Cont. Operations growth of 1.55% quarter on quarter, to $ 4.53 millions.

IV. Quarter 2023 The Pennant Group Inc 's results appear to be paradoxical, even if beneath the average, yet it shows absolute improvement relative to the -26.05% in the IV. Quarter 2022.

Within Medical Equipment & Supplies industry 24 other companies have achieved higher Income from Cont. Operations quarter on quarter growth. While The Pennant Group Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is 563.


The Pennant Group Inc 's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Income from Cont. Operations 12 Months Ending $ 13.91 $ 13.07 $ 13.60 $ 8.08 $ 7.24
Y / Y Income from Cont. Operations Growth (TTM) 92.05 % 988.09 % - 237.74 % 237.2 %
Year on Year Income from Cont. Operations Growth Overall Ranking # 58 # 1224 # 1648 # 1282 # 1129
Seqeuential Income from Cont. Operations Change (TTM) 6.44 % -3.91 % 68.28 % 11.58 % 503.08 %
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # 28 # 33 # 691 # 1245 # 1252




Cumulative Income from Cont. Operations growth Comment
With the quarterly Income from Cont. Operations reported in the Dec 31 2023 period, The Pennant Group Inc 's cumulative twelve months Income from Cont. Operations were $ 14 millions, company would post below average annual Income from Cont. Operations growth of 503.08% year on year, if the fiscal year would end at Dec 31 2023.
A slow-down in the The Pennant Group Inc 's Income from Cont. Operations growth from the 4.46% growth in Sep 30 2023. Despite that, The Pennant Group Inc showed the highest Income from Cont. Operations growth, among it's peers in Medical Equipment & Supplies industry.

Among companies within the Healthcare sector 2 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Total ranking has impoved so far to 58, from total ranking in previous quarter at 1224.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
988.09 %
122.08 %
-123 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 1
Healthcare Sector # 3
Overall # 58

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
988.09 %
122.08 %
-123 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 3
S&P 500 # 28
Cumulative Income from Cont. Operations growth Comment
With the quarterly Income from Cont. Operations reported in the Dec 31 2023 period, The Pennant Group Inc 's cumulative twelve months Income from Cont. Operations were $ 14 millions, company would post below average annual Income from Cont. Operations growth of -123% year on year, if the fiscal year would end at Dec 31 2023.
A slow-down in the The Pennant Group Inc 's Income from Cont. Operations growth from the 4.46% growth in Sep 30 2023. Despite that, The Pennant Group Inc showed the highest Income from Cont. Operations growth, among it's peers in Medical Equipment & Supplies industry.

Among companies within the Healthcare sector 2 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Total ranking has impoved so far to 58, from total ranking in previous quarter at 1224.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
988.09 %
122.08 %
-123 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 1
Healthcare Sector # 3
Overall # 58

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
988.09 %
122.08 %
-123 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 3
S&P 500 # 28




Other Income from Cont. Operations Growth
Medical Equipment & Supplies Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
PNTG's Income from Cont. Operations Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for PNTG's Competitors
Income from Cont. Operations Growth for The Pennant Group Inc 's Suppliers
Income from Cont. Operations Growth for PNTG's Customers

You may also want to know
PNTG's Annual Growth Rates PNTG's Profitability Ratios PNTG's Asset Turnover Ratio PNTG's Dividend Growth
PNTG's Roe PNTG's Valuation Ratios PNTG's Financial Strength Ratios PNTG's Dividend Payout Ratio
PNTG's Roa PNTG's Inventory Turnover Ratio PNTG's Growth Rates PNTG's Dividend Comparisons



Companies with similar Income from Cont. Operations growth for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Dec 31 2023
Ufp Technologies Inc 37.18%$ 37.178 millions
Catalyst Pharmaceuticals Inc 36.80%$ 36.799 millions
National Research Corporation33.38%$ 33.384 millions
West Pharmaceutical Services Inc 33.01%$ 33.010 millions
Hologic Inc31.54%$ 31.537 millions
Semler Scientific Inc 31.25%$ 31.250 millions
Takeda Pharmaceutical Company Limited30.34%$ 30.344 millions
Orasure Technologies Inc28.99%$ 28.987 millions
Conmed Corporation24.40%$ 24.402 millions
The Pennant Group Inc 22.84%$ 22.837 millions
Inmode Ltd 22.54%$ 22.535 millions
Option Care Health Inc 20.30%$ 20.299 millions
Vertex Pharmaceuticals Inc18.31%$ 18.305 millions
Avenue Therapeutics Inc 17.75%$ 17.748 millions
Steris Plc14.29%$ 14.287 millions
Medpace Holdings Inc 14.02%$ 14.021 millions
Zoetis Inc 13.70%$ 13.696 millions
Eli Lilly And Company13.01%$ 13.005 millions
Idexx Laboratories Inc12.96%$ 12.958 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com